Authors
Lozanskaya I.L., Larionova A.A.
S.M. Kirov Military medical academy, St. Petersburg
Abstract
The aim of the work is to examine various aspects of the development of acquired lacrimal duct strictures and the methods for their prevention. The methodology of the work involves an analysis of both domestic and international literature sources. The main findings from the literature review indicated that secondary dacryostenosis is a multifactorial complication, with the primary causes being excessive scarring, the body’s response to the stent, activation of opportunistic microflora, and recurrence of the primary disease. Current prevention strategies focus on suppressing excessive fibrosis through the use of antimetabolites (Mitomycin C), drug-eluting stents, bioabsorbable implants, and active postoperative endoscopic monitoring. A comprehensive approach combining these methods can significantly reduce the risk of restenosis and improve the long-term outcomes of surgical treatment.
Keywords: dacryostenosis, secondary dacryostenosis, dacryocystorhinostomy, restenosis, aetiology, prevention, postoperative complications.
References
1. Brzeski VV, Somov EE. Teardrop: physiology, research methods, clinic. St. Petersburg: Nauka; 1994. 156 p. (In Russ.)
2. Zhukov OV. An etiologically based approach to the treatment of relapse after dacricystorinostomy [dissertation]. M. N.: Federal State Budgetary Scientific Institution “Research Institute of Eye Diseases”; 2021. 131 p. (In Russ.)
3. Lopatin AS, Azizov IS, Kozlov RS.The microbiome of the nasal cavity and paranasal sinuses is normal and pathological. Part I. Russian rhinology. 2021; 29(1): 23-30. (In Russ.)
4. Novokshonov IA, Alyabyeva MYu. The use of mitomycin C for the prevention of restenosis after balloon dacryocystoplasty. Russian Ophthalmology online. 2021; 3: 45-50. (In Russ.)
5. Shkolnik SF. Minimally invasive technologies in the diagnosis and treatment of dacryostenosis and inflammatory diseases of the lacrimal tract. M.: MNTK Eye Microsurgery named after Fedorov, 2020. 334 p. (In Russ.)
6. Ali MJ, Paulsen F. The pathogenesis of primary acquired nasolacrimal duct obstruction: a window into the etiology of postsurgical restenosis. Ophthalmic Plastic and Reconstructive Surgery. 2015; 31(5): 363–367.
7. Ali MJ, Psaltis AJ, Wormald PJ. The role of routine nasal endoscopy in the management of silicone stents after dacryocystorhinostomy. Ophthalmic Plastic and Reconstructive Surgery. 2019; 35(6): 548–551.
8. Feng YF, Cai JQ, Zhang JY, Han XH. A meta-analysis of primary external dacryocystorhinostomy with and without silicone intubation. Canadian Journal of Ophthalmology. 2011; 46(6): 521–527.
9. Jung SK, Kim YC, Lee SY., et al. Prevention of fibrosis in a rabbit model of nasolacrimal duct injury with a paclitaxel-coated balloon. Translational Vision Science & Technology. 2021; 10(1): 15.
10. Kamal S, Ali MJ, Naik MN. Primary balloon dacryocystoplasty with intraoperative mitomycin C: a prospective randomized controlled trial. Orbit. 2015; 34(4): 197–200.
11. Kao SC, Liao CL, Tseng JH, Chen MS, Hou P.K. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology. 1997; 104(1): 86–91.
12. Kashkouli MB, Karimi N, Khademi B. Management of failed dacryocystorhinostomy: a systematic review and meta-analysis. European Journal of Ophthalmology. 2020; 30(4): 630–642.
13. Liang X, Shen Y, Jiang S, Li Z, Zhang L. Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. American Journal of Rhinology & Allergy. 2022; 36(1): 141–151.
14. Linberg JV, McCormick SA. The histopathology of canalicular stenosis. Ophthalmic Plastic and Reconstructive Surgery. 1986; 2(2): 85–91.
15. Lu LJ, Liu J. Human microbiota and ophthalmic disease. Yale Journal of Biology and Medicine. 2016; 89(3): 325–330.
16. Prabhakaran VC, Saeed P, Esmaeli B, et al. Nasolacrimal duct obstruction and orbital inflammatory disease in patients with sarcoidosis. Ophthalmology. 2008; 115(11): 2016–2019.
17. Toledano FN, García SS, Arteaga SA., et al. Dacriocistitis micótica asociada a prótesis naso-lagrimal. Caso clínico. Archivos de la Sociedad Española de Oftalmología. 2002; 77(7): 389–392.


